Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients

COMy 2022: Multiple myeloma roundup

Giving abatacept after checkpoint inhibitors can improve immunotherapy responses in melanoma

Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100

Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for resectable NSCLC

Advance Prostate Cancer Consensus Conference 2021: Report

Biomedicine and the soul

Recent advances in the treatment of patients with exon 20 insertion-positive NSCLC

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours

Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC

METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours

Real-world increase in biomarker testing in lung cancer